Breaking News, Collaborations & Alliances

Phyton Biotech Partners with PellePharm

Will develop renewable supply of cyclopamine for topical cancer therapy

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Phyton Biotech and PellePharm have formed a partnership to develop a plant cell culture-based process to enable the future renewable production of the raw material for PellePharm’s patidegib, an investigational topical therapy for Gorlin Syndrome and High Frequency Basal Cell Carcinoma (BCC). PellePharm is currently investigating the safety and efficacy of patidegib topical gel for the reduction of surgically-eligible BCCs in Gorlin Syndrome patients in a Phase 3 trial.   The foundation for this...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters